CHINATRIALS 11 Summit Advisory Board

PJ Chen
Vice President, Global Clinical Development/Regulatory Affairs and President
UNITED NEUROSCIENCE TAIWAN
Tong Guo
Vice President, Head of Business Development, Greater China
IQVIA
Ye Hua
Senior Vice President, Head Clinical Development & Regulatory Affairs
HUTCHISON MEDIPHARMA
Min Irwin
Chief Executive Officer
REISTONE BIOPHARMA
Frank Jiang
Chief Executive Officer
CSTONE PHARMA
Helen Jiang
Senior Vice President & Chief Medical Officer
QINGFENG MEDICINE
Simon Li
Vice President, Chief Medical Officer
CSPC
Jay Mei
Chief Executive Officer
ANTENGENE
Lingshi Tan
Chairman & Chief Executive Officer
DMED
Heidi Wang
Vice President, Head of Global Regulatory Science – China, including Hong Kong
BRISTOL-MYERS SQUIBB
Jingsong Wang
Chief Executive Officer
HARBOUR BIOMED
Jonathan Wang
Senior Managing Director
ORBIMED
Lin Wang
Head of Takeda Development Center; Asia Vice President, Global Medical Science & Development Operation, R&D
TAKEDA
Jason Yang
Chief Medical Officer & Senior Vice President, Clinical Development
CSTONE PHARMACEUTICALS